These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18081837)

  • 1. Abnormal medial prefrontal cortex connectivity and defective fear extinction in the presymptomatic G93A SOD1 mouse model of ALS.
    Sgobio C; Trabalza A; Spalloni A; Zona C; Carunchio I; Longone P; Ammassari-Teule M
    Genes Brain Behav; 2008 Jun; 7(4):427-34. PubMed ID: 18081837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Fogarty MJ; Mu EW; Noakes PG; Lavidis NA; Bellingham MC
    Acta Neuropathol Commun; 2016 Aug; 4(1):77. PubMed ID: 27488828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
    Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
    Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.
    Zhang B; Tu P; Abtahian F; Trojanowski JQ; Lee VM
    J Cell Biol; 1997 Dec; 139(5):1307-15. PubMed ID: 9382875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Traumatic Brain Injury Reduces Spine Density of Projection Neurons in the Medial Prefrontal Cortex and Impairs Extinction of Contextual Fear Memory.
    Zhao J; Huynh J; Hylin MJ; O'Malley JJ; Perez A; Moore AN; Dash PK
    J Neurotrauma; 2018 Jan; 35(1):149-156. PubMed ID: 28665166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-Dependent Vulnerability of Lumbar Motor Neuron Dendritic Degeneration in SOD1
    Fogarty MJ; Mu EWH; Lavidis NA; Noakes PG; Bellingham MC
    Anat Rec (Hoboken); 2020 May; 303(5):1455-1471. PubMed ID: 31509351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex.
    Walker AG; Ummel JR; Rebec GV
    Neurobiol Dis; 2011 Aug; 43(2):379-87. PubMed ID: 21515374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postsynaptic alteration of NR2A subunit and defective autophosphorylation of alphaCaMKII at threonine-286 contribute to abnormal plasticity and morphology of upper motor neurons in presymptomatic SOD1G93A mice, a murine model for amyotrophic lateral sclerosis.
    Spalloni A; Origlia N; Sgobio C; Trabalza A; Nutini M; Berretta N; Bernardi G; Domenici L; Ammassari-Teule M; Longone P
    Cereb Cortex; 2011 Apr; 21(4):796-805. PubMed ID: 20732897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue.
    Vallarola A; Sironi F; Tortarolo M; Gatto N; De Gioia R; Pasetto L; De Paola M; Mariani A; Ghosh S; Watson R; Kalmes A; Bonetto V; Bendotti C
    J Neuroinflammation; 2018 Mar; 15(1):65. PubMed ID: 29495962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the neurochemical profiles in the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Lei H; Dirren E; Poitry-Yamate C; Schneider BL; Gruetter R; Aebischer P
    J Cereb Blood Flow Metab; 2019 Jul; 39(7):1283-1298. PubMed ID: 29400109
    [TBL] [Abstract][Full Text] [